NuVasive 2Q17 Revenue and Organizational Changes
NuVasive reported 2Q17 revenue of US $260.6MM, +10.3% vs. 2Q16, and 1H17 revenue of $510.4MM, +13.1% vs. 1H16. Aug 03, 2017
SpineSource Awarded DOD Contract for L-Varlock Expandable Cage
SpineSource was awarded a contract to supply the U.S. Department of Defense with the L-Varlock® expandable lumbar cage. Aug 02, 2017
SI-BONE Maintains Exclusive Positive Coverage with Blue Cross and Blue Shield
Blue Cross and Blue Shield has updated its coverage policy for MIS SI joint fusion in various states, and maintained an exclusive positive coverage for SI-BONE’s iFuse Implant. Aug 02, 2017
Stryker Reports 2Q17 Revenue
ORTHOWORLD estimates Stryker’s 2Q17 orthopaedic revenue at US $1,618.7MM, +4.0% from 2Q16, and 1H17 revenue of $3,230.9MM, +4.9% vs. 1H16. Aug 02, 2017
Zimmer Biomet Orthopaedic Revenue for 2Q17
ORTHOWORLD estimates Zimmer Biomet 2Q17 orthopaedic revenue of US $1,816.0MM, +2.6% from 2Q16, and 1H17 revenue of $3,652.1MM, +3.7% vs. 1H16. Aug 02, 2017
Titan Spine Doubles nanoLOCK Surgeon Users
In 2Q17 vs. 1Q17, Titan Spine posted a +42% sequential increase in nanoLOCK® surface technology device sales volume. Aug 02, 2017
MiMedx Plantar Fasciitis Clinical Trial Underway
MiMedx commenced a Phase III study to evaluate AmnioFix Injectable allograft vs. placebo in the treatment of Plantar Fasciitis. Aug 02, 2017
AlloSource Launches AlloFuse Cellular Allograft Matrix
AlloSource launched AlloFuse® Select CM cellular allograft for use in spinal, orthopaedic and neurologic procedures. Aug 01, 2017
Medicrea Announces First MIS Spine Surgery with Patient-Specific Implants
Medicrea announced completion of the world’s first minimally invasive spine procedure using patient-specific implants, with the UNiD™ MIS Rod. Aug 01, 2017
Integra LifeSciences 2Q17 Orthopaedic Revenue
ORTHOWORLD estimates Integra LifeSciences’ 2Q17 orthopaedic revenue at US $37.3MM, +34.1% from 2Q16, and 1H17 revenue of $68.5MM, +27.1% vs. 1H16. Aug 01, 2017
